España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Agile Therapeutics Inc COM PAR $0.0001
AGRX
OTC
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Agile Therapeutics Inc COM PAR $0.0001 (AGRX) Forecast
News
Earnings
Agile Therapeutics Inc COM PAR $0.0001 (AGRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Agile Therapeutics Inc COM PAR $0.0001 (OTC:AGRX) Stock
Agile Therapeutics Inc COM PAR $0.0001 Stock (OTC: AGRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 15, 2024
Agile Therapeutics Q1 2024 Adj EPS $(0.63) Mi...
Benzinga Newsdesk
Thursday, March 28, 2024
Agile Therapeutics Q4 Adj $(1.46) Misses $(0....
Benzinga Newsdesk
Agile Therapeutics: Q4 Earnings Insights
Benzinga Insights
Wednesday, March 27, 2024
Agile Therapeutics's Earnings: A Preview
Benzinga Insights
Tuesday, March 26, 2024
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Henry Khederian
Monday, March 25, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Agile Therapeutics shares are trading lower a...
Benzinga Newsdesk
Agile Therapeutics Reveals Final Delisting No...
Benzinga Newsdesk
Friday, March 22, 2024
Earnings Scheduled For March 22, 2024
Benzinga Insights
Thursday, March 21, 2024
Agile Therapeutics's Earnings: A Preview
Benzinga Insights
Monday, March 18, 2024
Maxim Group Downgrades Agile Therapeutics to ...
Benzinga Newsdesk
Wednesday, March 13, 2024
Agile Therapeutics shares are trading higher ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Agile Therapeutics Announced That It Has Paid...
Benzinga Newsdesk
Monday, March 04, 2024
'France becomes first country to explicitly e...
Benzinga Newsdesk
Thursday, February 22, 2024
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
Vandana Singh
Agile Therapeutics Announces Exercise of Warr...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, February 19, 2024
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Thursday, February 15, 2024
Agile Therapeutics Announces Extension Grante...
Benzinga Newsdesk
Tuesday, January 23, 2024
The Biden-Harris Administration Announces New...
Benzinga Newsdesk
Monday, January 22, 2024
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Monday, January 15, 2024
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Tuesday, January 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Tuesday, December 12, 2023
Agile Therapeutics Provides Update On Actions...
Benzinga Newsdesk
Wednesday, December 06, 2023
Agile Therapeutics Received A Letter Notifyin...
Benzinga Newsdesk
Tuesday, November 21, 2023
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
Meg Flippin
-
Sponsored
Thursday, November 09, 2023
Agile Therapeutics Reaffirms Expected Full Ye...
Benzinga Newsdesk
Agile Therapeutics' Twirla Delivered $6.7M In...
Benzinga Newsdesk
Agile Therapeutics Q3 Adjusted EPS $(1.47) Be...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights
Monday, October 16, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Wednesday, September 27, 2023
Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group
Johnny Rice
-
Sponsored
Monday, September 25, 2023
5 Value Stocks To Watch In The Healthcare Sector
Benzinga Insights
Friday, September 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Benzinga Insights
Maxim Group Upgrades Agile Therapeutics to Bu...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Tuesday, September 19, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Thursday, August 17, 2023
Agile Says It's On Track To Hit $25M-$30M Net Annual Revenue After A Strong Performance In Q2
Happy Mohamed
Wednesday, August 16, 2023
Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
Rachael Green
-
Sponsored
Monday, August 14, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
UPDATE: Agile Therapeutics Q2 Adj $(3.10) Bea...
Benzinga Newsdesk
Agile Therapeutics Q2 Adj $(3.10) Beats $(3.4...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Tuesday, July 18, 2023
Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
Happy Mohamed
Monday, July 17, 2023
This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions Of Women Thanks To A Partnership With Afaxys
Rachael Green
-
Sponsored
Show More